EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Clinical trial NCT07064473 · RECRUITING

Trial details

NCT number: NCT07064473
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Hypertension Cardiovascular Diseases

Start date: 2025-07-22
Primary completion: 2029-12-14
Enrollment: 11800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.